Substance P is a signaling molecule that carries pain messages from your body to your brain, triggers inflammation, influences your mood, and helps control the vomiting reflex. It is an 11-amino-acid neuropeptide produced by the central nervous system, peripheral nervous system, and immune cells. As the first discovered member of the tachykinin family of neuropeptides, substance P plays a surprisingly wide range of roles, from amplifying a stubbed toe to shaping your emotional response to stress.
How Substance P Transmits Pain
Substance P’s most well-known job is relaying pain signals. When you experience an injury or tissue damage, small nerve fibers called nociceptors fire off signals that travel from the site of injury to the spinal cord. Substance P is released at the connection point in the dorsal horn of the spinal cord, where it activates a receptor called the neurokinin-1 receptor (NK1R) on the next nerve cell in the chain. This doesn’t just pass the message along. It amplifies it.
Substance P boosts the activity of glutamate, the brain’s main excitatory chemical messenger. Normally, glutamate handles the fast, sharp component of a pain signal. Substance P layers on top of that by making nerve cells more responsive to glutamate, effectively turning up the volume on pain. It does this by triggering a cascade inside the cell that enhances the function of specific glutamate receptors, producing a slower, longer-lasting wave of excitation. This is why blocking substance P with an antagonist selectively reduces the prolonged, burning pain that follows intense stimulation, rather than the initial sharp sensation.
During inflammation, something important happens: primary nerve fibers release extra substance P, which causes the receiving neurons in the spinal cord to produce more NK1 receptors on their surface. More receptors means the system becomes increasingly sensitive to pain signals over time. This is one mechanism behind chronic pain, where the nervous system essentially rewires itself to stay in a heightened state of alert long after the original injury should have healed. The highest concentrations of substance P in the nervous system are found in the dorsal horn of the spinal cord, the substantia nigra, and the amygdala.
Triggering Inflammation
Beyond carrying pain signals through the nervous system, substance P directly fuels inflammation at the site of injury. When released from nerve endings in the skin, lungs, gut, or other organs, it causes blood vessels to widen and become more permeable. This process, called neurogenic inflammation, allows immune cells to flood into the affected tissue more easily. At the cellular level, substance P causes the inner lining of blood vessels to retract, creating gaps that let fluid and white blood cells pass through vessel walls.
This is why injuries swell. Substance P is one of the key chemical drivers behind the redness, warmth, and puffiness you see around a wound or irritated tissue. It essentially bridges the nervous system and the immune system, ensuring that when your nerves detect damage, your immune response kicks in quickly.
The Vomiting Reflex
Substance P plays a central role in nausea and vomiting. Specialized cells in the lining of the gastrointestinal tract, called enterochromaffin cells, produce large amounts of substance P alongside serotonin. When these cells detect something harmful (a toxic drug, a bacterial infection, physical irritation), they release both chemicals in a calcium-dependent process.
Once released, substance P activates NK1 receptors on nearby nerve fibers that connect to the brainstem. The signal travels to an area called the nucleus of the solitary tract, which acts as the brain’s integration center for the vomiting reflex. Importantly, unlike serotonin, substance P has an active transport mechanism that lets it reach brainstem emetic centers directly through the bloodstream. This makes it especially important in delayed nausea, the kind that lingers hours or days after chemotherapy.
This discovery led to a practical medical breakthrough. NK1 receptor blockers are now FDA-approved to prevent nausea and vomiting caused by chemotherapy and surgery. These medications work by preventing substance P from activating its receptor in the brainstem, effectively silencing one of the two major pathways that trigger vomiting.
Anxiety and Emotional Stress
The amygdala, a brain region critical for processing fear and emotion, is packed with both substance P-producing neurons and NK1 receptors. Research in rats has shown that emotional stress causes a dramatic spike in substance P release in a specific part of the amygdala called the medial nucleus. Immobilization stress, a model for severe emotional distress, triggered a 150% increase in substance P release in that region. Even mild stress, like exposure to an elevated platform, caused a 40% increase.
That spike in substance P directly increased anxiety-related behavior. When researchers injected substance P into the medial amygdala of unstressed rats, the animals showed clear signs of heightened anxiety: they avoided open, exposed areas and spent more time in sheltered zones. Conversely, injecting an NK1 receptor blocker into the same brain region completely blocked the anxiety response to stress. These findings identified the medial amygdala as a critical site where substance P shapes anxiety, and they explain why NK1 receptor blockers have shown promise in relieving symptoms of both depression and anxiety in human clinical trials.
Wound Healing and Tissue Repair
Substance P also contributes to repair after injury. In skin wound models, it accelerates healing by promoting the growth of new blood vessels (angiogenesis) and enhancing the migration of stem-like cells to the wound site. It has been shown to improve healing in diabetic corneal wounds, where nerve damage typically slows recovery. Topical application of substance P enhanced the closure of open wounds in animal studies. Because impaired blood vessel growth is a hallmark of chronic, non-healing wounds, substance P’s ability to stimulate angiogenesis makes it a target of interest for improving tissue repair in difficult cases.
Why Blocking Substance P Is Harder Than It Sounds
Given how many problems substance P contributes to, blocking it seems like an obvious strategy. In practice, results have been mixed. NK1 receptor blockers have succeeded clearly in one area: preventing chemotherapy-induced and post-surgical nausea. For chronic pain, however, clinical trials of NK1 antagonists have been largely disappointing, likely because pain processing involves many overlapping chemical systems that can compensate when one is blocked.
There is also a safety concern. NK1 antagonists have been associated with serious side effects in some patients, including severe skin reactions, dangerously low white blood cell counts, and heart rhythm changes. These risks have limited the enthusiasm for broader use. Most current research on NK1 blockers remains focused on their established role as anti-nausea drugs rather than expanding into pain or psychiatric conditions, despite the biological rationale for doing so.